Skip to main content
Clinical Trials/NCT04992572
NCT04992572
Recruiting
Early Phase 1

Randomized Study Comparing Local/ MAC Anesthesia to General for 1-3 Level Lumbar Decompressions

Stanford University2 sites in 1 country100 target enrollmentDecember 1, 2021

Overview

Phase
Early Phase 1
Intervention
Propofol Injection
Conditions
Lumbar Spinal Stenosis
Sponsor
Stanford University
Enrollment
100
Locations
2
Primary Endpoint
Change in Oswestry Disability Index (ODI) score
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

Explore efficacy, complications, and other factors associated with anaesthetic choice- To evaluate the efficacy of local + MAC as an alternative anesthetic to general anesthesia and to analyze patients' outcomes and experiences.

Detailed Description

100 Patients ages 40-95 with lumbar stenosis to be decompressed are randomized to undergo the procedure with either general anesthesia or local anesthetic with MAC. Participants will be randomized to either group 1 General anesthesia or group 2 Local + MAC anesthetic group. Group 1: General Anesthesia: Medically induced unconsciousness that suppresses reflexes and requires intubation (a tube inserted through the mouth and into the airway) to assist in breathing. Group 2: Local + MAC: Local anesthetic (lidocaine) injected into the site of the incision/dissection with additional IV medication (Propofol) to achieve a state in which the patient is generally aware, but relaxed

Registry
clinicaltrials.gov
Start Date
December 1, 2021
End Date
December 31, 2028
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Todd Alamin

Professor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Patients with lumbar stenosis to be decompressed over 1-3 segments
  • Ages 40-95
  • Appropriate for general anesthesia

Exclusion Criteria

  • Planned significant nerve root retraction
  • Previous fusion operation
  • Unable to comply with follow up
  • Patients with daily morphine equivalents or more 100mg
  • Patients with a known hypersensitivity to propofol or any of DIPRIVAN Injectable Emulsion components.
  • Patients with allergies to eggs, egg products, soybeans or soy products.

Arms & Interventions

General anesthesia

Patients under this group will be undergoing lumbar decompression surgery with general anesthesia: General Anesthesia: Medically induced unconsciousness that suppresses reflexes and requires intubation (a tube inserted through the mouth and into the airway) to assist in breathing.

Intervention: Propofol Injection

Monitored Anesthetic Care (MAC)/Local

Patients under this group wil be undergoing limbar decompression surgery with Monitored Anesthetic care, (MAC)/Local. Local + MAC: Local anesthetic (lidocaine) injected into the site of the incision/dissection with additional IV medication (Propofol) to achieve a state in which the patient is generally aware, but relaxed.

Intervention: Lidocaine Hydrochloride, Injectable

Outcomes

Primary Outcomes

Change in Oswestry Disability Index (ODI) score

Time Frame: Basline through year 2

Scale is expressed as a percentage (0 to 100%). Higher score indicates more severe disability.

Change in patient reported pain

Time Frame: Basline through year 2

Measured on visual analog scale (VAS). Score range 0-10, 0= no pain and 10 = worst pain.

Study Sites (2)

Loading locations...

Similar Trials